log-binomial regression models using the stata command glm Search Results


99
STATA Corporation fu visit m12
Proportion (%) of patients with immunosuppressant therapies, at baseline and at visit <t>M12.</t>
Fu Visit M12, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log-binomial+regression+models+using+the+stata+command+glm/STATA+1%2E0/pmc10174308-99-21-29
Average 99 stars, based on 1 article reviews
fu visit m12 - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

90
RStudio general linear model (glm) function
Proportion (%) of patients with immunosuppressant therapies, at baseline and at visit <t>M12.</t>
General Linear Model (Glm) Function, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log-binomial+regression+models+using+the+stata+command+glm/general+linear+model/10__1080_slash_17550874__2023__2274844-122-20-30
Average 90 stars, based on 1 article reviews
general linear model (glm) function - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

99
STATA Corporation version 7 0
Proportion (%) of patients with immunosuppressant therapies, at baseline and at visit <t>M12.</t>
Version 7 0, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log-binomial+regression+models+using+the+stata+command+glm/STATA+7%2E0/pm37794385-98-36-35
Average 99 stars, based on 1 article reviews
version 7 0 - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

97
SAS institute model glm
Proportion (%) of patients with immunosuppressant therapies, at baseline and at visit <t>M12.</t>
Model Glm, supplied by SAS institute, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log-binomial+regression+models+using+the+stata+command+glm/SAS+Model+Risk+Management/pmc01571121-117-35-41
Average 97 stars, based on 1 article reviews
model glm - by Bioz Stars, 2026-08
97/100 stars
  Buy from Supplier

99
STATA Corporation stata v15
Proportion (%) of patients with immunosuppressant therapies, at baseline and at visit <t>M12.</t>
Stata V15, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log-binomial+regression+models+using+the+stata+command+glm/STATA+15%2E0/pmc12181017-89-31-31
Average 99 stars, based on 1 article reviews
stata v15 - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

99
STATA Corporation version 14
Proportion (%) of patients with immunosuppressant therapies, at baseline and at visit <t>M12.</t>
Version 14, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log-binomial+regression+models+using+the+stata+command+glm/STATA+14%2E0/pmc06140005-172-9-8
Average 99 stars, based on 1 article reviews
version 14 - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

99
STATA Corporation glm command
Proportion (%) of patients with immunosuppressant therapies, at baseline and at visit <t>M12.</t>
Glm Command, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log-binomial+regression+models+using+the+stata+command+glm/STATA+13%2E0/10__1016_slash_j__jveb__2016__06__010-107-20-24
Average 99 stars, based on 1 article reviews
glm command - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

99
STATA Corporation cohortspecific recruitment
Proportion (%) of patients with immunosuppressant therapies, at baseline and at visit <t>M12.</t>
Cohortspecific Recruitment, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log-binomial+regression+models+using+the+stata+command+glm/STATA+8%2E0/pm17302841-129-0-5
Average 99 stars, based on 1 article reviews
cohortspecific recruitment - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

99
STATA Corporation stata 16 0
Proportion (%) of patients with immunosuppressant therapies, at baseline and at visit <t>M12.</t>
Stata 16 0, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log-binomial+regression+models+using+the+stata+command+glm/STATA+16%2E0/10__1097_slash_js9__0000000000000364-72-43-43
Average 99 stars, based on 1 article reviews
stata 16 0 - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

99
STATA Corporation equation gee
Proportion (%) of patients with immunosuppressant therapies, at baseline and at visit <t>M12.</t>
Equation Gee, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log-binomial+regression+models+using+the+stata+command+glm/STATA+2%2E0/10__1128_slash_aem__02624___07-104-45-48
Average 99 stars, based on 1 article reviews
equation gee - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

99
STATA Corporation hypothesis 33
Proportion (%) of patients with immunosuppressant therapies, at baseline and at visit <t>M12.</t>
Hypothesis 33, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log-binomial+regression+models+using+the+stata+command+glm/STATA+11%2E0/10__2105_slash_ajph__2013__301488-69-66-71
Average 99 stars, based on 1 article reviews
hypothesis 33 - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

99
STATA Corporation equations gee
Proportion (%) of patients with immunosuppressant therapies, at baseline and at visit <t>M12.</t>
Equations Gee, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/log-binomial+regression+models+using+the+stata+command+glm/STATA+10%2E0/pm24135612-103-36-39
Average 99 stars, based on 1 article reviews
equations gee - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

Image Search Results


Proportion (%) of patients with immunosuppressant therapies, at baseline and at visit M12.

Journal: Frontiers in Pharmacology

Article Title: Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN)

doi: 10.3389/fphar.2023.1040584

Figure Lengend Snippet: Proportion (%) of patients with immunosuppressant therapies, at baseline and at visit M12.

Article Snippet: Finally, we investigated associations between QoL measures (EQ-5D and VAS) and types of therapies using generalized linear models, estimated in the FU visit (M12) (GLM, family binomial, link logit, Stata software, 17.0).

Techniques:

EQ-5D at closing  visit M12  and improvement of EQ-5D over the whole observation period.

Journal: Frontiers in Pharmacology

Article Title: Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN)

doi: 10.3389/fphar.2023.1040584

Figure Lengend Snippet: EQ-5D at closing visit M12 and improvement of EQ-5D over the whole observation period.

Article Snippet: Finally, we investigated associations between QoL measures (EQ-5D and VAS) and types of therapies using generalized linear models, estimated in the FU visit (M12) (GLM, family binomial, link logit, Stata software, 17.0).

Techniques:

VAS scores at closing  visit M12  and improvement of VAS score over the whole observation period.

Journal: Frontiers in Pharmacology

Article Title: Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN)

doi: 10.3389/fphar.2023.1040584

Figure Lengend Snippet: VAS scores at closing visit M12 and improvement of VAS score over the whole observation period.

Article Snippet: Finally, we investigated associations between QoL measures (EQ-5D and VAS) and types of therapies using generalized linear models, estimated in the FU visit (M12) (GLM, family binomial, link logit, Stata software, 17.0).

Techniques:

Improvement in raw scores (EQ-5D or VAS from baseline to  visit M12,  presented in odds ratios).

Journal: Frontiers in Pharmacology

Article Title: Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN)

doi: 10.3389/fphar.2023.1040584

Figure Lengend Snippet: Improvement in raw scores (EQ-5D or VAS from baseline to visit M12, presented in odds ratios).

Article Snippet: Finally, we investigated associations between QoL measures (EQ-5D and VAS) and types of therapies using generalized linear models, estimated in the FU visit (M12) (GLM, family binomial, link logit, Stata software, 17.0).

Techniques: